Trial Outcomes & Findings for Recovery Support for Bladder Cancer Patients and Caregivers (NCT NCT04055311)

NCT ID: NCT04055311

Last Updated: 2026-03-19

Results Overview

Bladder cancer survivor quality of life was assessed using the 42-item FACT-BL-CYS, which employed a 5-point Likert-type scale ranging from 0-4. Scale was computed as per published instructions: Higher summary and subscale scores indicated better quality of life. Median imputation at the item level was performed if at least 2/3 of items per subscales had responses. Potential score range for each subscale: Physical well-being (7 items): 0-28; Social/family well-being (7 items): 0-28; Emotional well-being (6 items): 0-24; Functional well-being (7 items): 0-28; BL-CYS well-being (15 items): 0-60. Potential score range for total score: 0-168

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

174 participants

Primary outcome timeframe

Baseline

Results posted on

2026-03-19

Participant Flow

Bladder cancer survivor patients and associated caregivers were recruited from Northwell Health and Fox Chase Cancer Center/Temple University Hospital between October 2018 to June 2024. The study team reviewed electronic medical records, screening physicians' schedules for eligible survivors and leveraged physician referrals for recruitment. Following identification of eligible patient survivors, their associated caregivers were also assessed for eligibility and approached for recruitment.

N = 174 participants (109 patient survivors, 65 caregivers) met study inclusion criteria and were enrolled in study. While this is not a dyad study, patients and caregivers who opted to participate were randomly assigned to the same conditions (i.e., intervention or enhanced usual care control arm). Our analyses comprised the following groups: (Intervention (Survivors), N = 47; Intervention (Caregivers), N = 31; Usual Care Enhanced (Survivors), N = 62, Usual Care Enhanced (Caregivers), N = 34.

Participant milestones

Participant milestones
Measure
Intervention (Survivors)
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Intervention (Caregivers)
Caregivers of bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Usual Care Enhanced (Caregivers)
Caregivers of bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Overall Study
STARTED
47
31
62
34
Overall Study
1-month
39
24
53
30
Overall Study
3-month
37
21
51
30
Overall Study
6-month
36
21
49
31
Overall Study
12-month
28
16
38
26
Overall Study
COMPLETED
28
16
38
26
Overall Study
NOT COMPLETED
19
15
24
8

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention (Survivors)
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Intervention (Caregivers)
Caregivers of bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Usual Care Enhanced (Caregivers)
Caregivers of bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Overall Study
Death
4
0
6
0
Overall Study
Lost to Follow-up
8
9
10
5
Overall Study
Protocol Violation
0
0
1
0
Overall Study
Withdrawal by Subject
4
5
4
2
Overall Study
Survey incomplete since after data collection period
3
1
3
1

Baseline Characteristics

Recovery Support for Bladder Cancer Patients and Caregivers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention (Survivors)
n=47 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Intervention (Caregivers)
n=31 Participants
Caregivers of bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=62 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Usual Care Enhanced (Caregivers)
n=34 Participants
Caregivers of bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Total
n=174 Participants
Total of all reporting groups
Age, Continuous
66.69 Years
STANDARD_DEVIATION 9.54 • n=110 Participants
60.55 Years
STANDARD_DEVIATION 12.38 • n=114 Participants
67.10 Years
STANDARD_DEVIATION 9.83 • n=224 Participants
59.32 Years
STANDARD_DEVIATION 12.60 • n=104 Participants
64.27 Years
STANDARD_DEVIATION 11.28 • n=2 Participants
Sex: Female, Male
Female
11 Participants
n=110 Participants
26 Participants
n=114 Participants
20 Participants
n=224 Participants
31 Participants
n=104 Participants
88 Participants
n=2 Participants
Sex: Female, Male
Male
36 Participants
n=110 Participants
5 Participants
n=114 Participants
42 Participants
n=224 Participants
3 Participants
n=104 Participants
86 Participants
n=2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=110 Participants
0 Participants
n=114 Participants
0 Participants
n=224 Participants
1 Participants
n=104 Participants
1 Participants
n=2 Participants
Race (NIH/OMB)
Asian
0 Participants
n=110 Participants
0 Participants
n=114 Participants
0 Participants
n=224 Participants
1 Participants
n=104 Participants
1 Participants
n=2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=110 Participants
0 Participants
n=114 Participants
0 Participants
n=224 Participants
0 Participants
n=104 Participants
0 Participants
n=2 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=110 Participants
0 Participants
n=114 Participants
7 Participants
n=224 Participants
1 Participants
n=104 Participants
10 Participants
n=2 Participants
Race (NIH/OMB)
White
42 Participants
n=110 Participants
27 Participants
n=114 Participants
54 Participants
n=224 Participants
29 Participants
n=104 Participants
152 Participants
n=2 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=110 Participants
0 Participants
n=114 Participants
0 Participants
n=224 Participants
0 Participants
n=104 Participants
0 Participants
n=2 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=110 Participants
4 Participants
n=114 Participants
1 Participants
n=224 Participants
2 Participants
n=104 Participants
10 Participants
n=2 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=110 Participants
3 Participants
n=114 Participants
0 Participants
n=224 Participants
2 Participants
n=104 Participants
8 Participants
n=2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
43 Participants
n=110 Participants
28 Participants
n=114 Participants
61 Participants
n=224 Participants
32 Participants
n=104 Participants
164 Participants
n=2 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=110 Participants
0 Participants
n=114 Participants
1 Participants
n=224 Participants
0 Participants
n=104 Participants
2 Participants
n=2 Participants
Region of Enrollment
United States
47 Participants
n=110 Participants
31 Participants
n=114 Participants
62 Participants
n=224 Participants
34 Participants
n=104 Participants
174 Participants
n=2 Participants
Urinary Diversion Decision
Ileal conduit
31 Participants
n=110 Participants
22 Participants
n=114 Participants
40 Participants
n=224 Participants
21 Participants
n=104 Participants
114 Participants
n=2 Participants
Urinary Diversion Decision
Indiana pouch
1 Participants
n=110 Participants
2 Participants
n=114 Participants
4 Participants
n=224 Participants
2 Participants
n=104 Participants
9 Participants
n=2 Participants
Urinary Diversion Decision
Neobladder
12 Participants
n=110 Participants
6 Participants
n=114 Participants
17 Participants
n=224 Participants
11 Participants
n=104 Participants
46 Participants
n=2 Participants
Urinary Diversion Decision
Other
3 Participants
n=110 Participants
1 Participants
n=114 Participants
1 Participants
n=224 Participants
0 Participants
n=104 Participants
5 Participants
n=2 Participants

PRIMARY outcome

Timeframe: Baseline

Population: ITT

Bladder cancer survivor quality of life was assessed using the 42-item FACT-BL-CYS, which employed a 5-point Likert-type scale ranging from 0-4. Scale was computed as per published instructions: Higher summary and subscale scores indicated better quality of life. Median imputation at the item level was performed if at least 2/3 of items per subscales had responses. Potential score range for each subscale: Physical well-being (7 items): 0-28; Social/family well-being (7 items): 0-28; Emotional well-being (6 items): 0-24; Functional well-being (7 items): 0-28; BL-CYS well-being (15 items): 0-60. Potential score range for total score: 0-168

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=44 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=60 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
117.59 Quality of Life Score
Standard Deviation 21.68
118.70 Quality of Life Score
Standard Deviation 25.46

PRIMARY outcome

Timeframe: 1 month

Population: ITT

Bladder cancer survivor quality of life was assessed using the 42-item FACT-BL-CYS, which employed a 5-point Likert-type scale ranging from 0-4. Scale was computed as per published instructions: Higher summary and subscale scores indicated better quality of life. Median imputation at the item level was performed if at least 2/3 of items per subscales had responses. Potential score range for each subscale: Physical well-being (7 items): 0-28; Social/family well-being (7 items): 0-28; Emotional well-being (6 items): 0-24; Functional well-being (7 items): 0-28; BL-CYS well-being (15 items): 0-60. Potential score range for total score: 0-168

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=37 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=52 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
116.34 Quality of Life Score
Standard Deviation 22.94
106.82 Quality of Life Score
Standard Deviation 22.74

PRIMARY outcome

Timeframe: 3 months

Population: ITT

Bladder cancer survivor quality of life was assessed using the 42-item FACT-BL-CYS, which employed a 5-point Likert-type scale ranging from 0-4. Scale was computed as per published instructions: Higher summary and subscale scores indicated better quality of life. Median imputation at the item level was performed if at least 2/3 of items per subscales had responses. Potential score range for each subscale: Physical well-being (7 items): 0-28; Social/family well-being (7 items): 0-28; Emotional well-being (6 items): 0-24; Functional well-being (7 items): 0-28; BL-CYS well-being (15 items): 0-60. Potential score range for total score: 0-168

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=37 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=51 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
127.50 Quality of Life Score
Standard Deviation 18.14
119.98 Quality of Life Score
Standard Deviation 23.03

PRIMARY outcome

Timeframe: 6 months

Population: ITT

Bladder cancer survivor quality of life was assessed using the 42-item FACT-BL-CYS, which employed a 5-point Likert-type scale ranging from 0-4. Scale was computed as per published instructions: Higher summary and subscale scores indicated better quality of life. Median imputation at the item level was performed if at least 2/3 of items per subscales had responses. Potential score range for each subscale: Physical well-being (7 items): 0-28; Social/family well-being (7 items): 0-28; Emotional well-being (6 items): 0-24; Functional well-being (7 items): 0-28; BL-CYS well-being (15 items): 0-60. Potential score range for total score: 0-168

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=49 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
129.71 Quality of Life Score
Standard Deviation 21.51
121.29 Quality of Life Score
Standard Deviation 25.48

PRIMARY outcome

Timeframe: 12 months

Population: ITT

Bladder cancer survivor quality of life was assessed using the 42-item FACT-BL-CYS, which employed a 5-point Likert-type scale ranging from 0-4. Scale was computed as per published instructions: Higher summary and subscale scores indicated better quality of life. Median imputation at the item level was performed if at least 2/3 of items per subscales had responses. Potential score range for each subscale: Physical well-being (7 items): 0-28; Social/family well-being (7 items): 0-28; Emotional well-being (6 items): 0-24; Functional well-being (7 items): 0-28; BL-CYS well-being (15 items): 0-60. Potential score range for total score: 0-168

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=28 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=38 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Patient: The Functional Assessment of Cancer Therapy-Bladder Cancer-Cystectomy
130.46 Quality of Life Score
Standard Deviation 21.01
123.21 Quality of Life Score
Standard Deviation 24.73

PRIMARY outcome

Timeframe: Baseline

Population: ITT

Caregiver quality of life was assessed using an abbreviated version of the 35-item CQOLC, (including items 1, 3, 5, 6, 7, 8, 11, 14, 19, 22, 28, and 34) and employing a 5-point Likert type scale ranging from 0-4; items were reverse scored so that a higher score indicated better quality of life. Items were summed together to get a total score, and median imputation was completed at the item level if at least 2/3 of items asked had responses (8+ items). Potential score range for total score: 0-48. Potential score range for each subscale: Disruptiveness (3 items; items 1, 3, 5): 0-12; Financial concerns (3 items; items 6, 7, 8): 0-12; Emotional distress (3 items; items 11, 14, 19): 0-12; Positive adaptation (3 items; items 22, 28, 34): 0-12.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=28 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=33 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
34.29 Quality of Life Score
Standard Deviation 8.75
33.21 Quality of Life Score
Standard Deviation 8.28

PRIMARY outcome

Timeframe: 1 month

Population: ITT

Caregiver quality of life was assessed using an abbreviated version of the 35-item CQOLC, (including items 1, 3, 5, 6, 7, 8, 11, 14, 19, 22, 28, and 34) and employing a 5-point Likert type scale ranging from 0-4; items were reverse scored so that a higher score indicated better quality of life. Items were summed together to get a total score, and median imputation was completed at the item level if at least 2/3 of items asked had responses (8+ items). Potential score range for total score: 0-48. Potential score range for each subscale: Disruptiveness (3 items; items 1, 3, 5): 0-12; Financial concerns (3 items; items 6, 7, 8): 0-12; Emotional distress (3 items; items 11, 14, 19): 0-12; Positive adaptation (3 items; items 22, 28, 34): 0-12.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=23 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=30 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
32.07 Quality of Life Score
Standard Deviation 9.18
34.33 Quality of Life Score
Standard Deviation 6.08

PRIMARY outcome

Timeframe: 3 months

Population: ITT

Caregiver quality of life was assessed using an abbreviated version of the 35-item CQOLC, (including items 1, 3, 5, 6, 7, 8, 11, 14, 19, 22, 28, and 34) and employing a 5-point Likert type scale ranging from 0-4; items were reverse scored so that a higher score indicated better quality of life. Items were summed together to get a total score, and median imputation was completed at the item level if at least 2/3 of items asked had responses (8+ items). Potential score range for total score: 0-48. Potential score range for each subscale: Disruptiveness (3 items; items 1, 3, 5): 0-12; Financial concerns (3 items; items 6, 7, 8): 0-12; Emotional distress (3 items; items 11, 14, 19): 0-12; Positive adaptation (3 items; items 22, 28, 34): 0-12.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=21 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=30 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
34.05 Quality of Life Score
Standard Deviation 6.79
35.90 Quality of Life Score
Standard Deviation 7.74

PRIMARY outcome

Timeframe: 6 months

Population: ITT

Caregiver quality of life was assessed using an abbreviated version of the 35-item CQOLC, (including items 1, 3, 5, 6, 7, 8, 11, 14, 19, 22, 28, and 34) and employing a 5-point Likert type scale ranging from 0-4; items were reverse scored so that a higher score indicated better quality of life. Items were summed together to get a total score, and median imputation was completed at the item level if at least 2/3 of items asked had responses (8+ items). Potential score range for total score: 0-48. Potential score range for each subscale: Disruptiveness (3 items; items 1, 3, 5): 0-12; Financial concerns (3 items; items 6, 7, 8): 0-12; Emotional distress (3 items; items 11, 14, 19): 0-12; Positive adaptation (3 items; items 22, 28, 34): 0-12.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=21 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=31 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
35.90 Quality of Life Score
Standard Deviation 8.90
35.00 Quality of Life Score
Standard Deviation 8.92

PRIMARY outcome

Timeframe: 12 months

Population: ITT

Caregiver quality of life was assessed using an abbreviated version of the 35-item CQOLC, (including items 1, 3, 5, 6, 7, 8, 11, 14, 19, 22, 28, and 34) and employing a 5-point Likert type scale ranging from 0-4; items were reverse scored so that a higher score indicated better quality of life. Items were summed together to get a total score, and median imputation was completed at the item level if at least 2/3 of items asked had responses (8+ items). Potential score range for total score: 0-48. Potential score range for each subscale: Disruptiveness (3 items; items 1, 3, 5): 0-12; Financial concerns (3 items; items 6, 7, 8): 0-12; Emotional distress (3 items; items 11, 14, 19): 0-12; Positive adaptation (3 items; items 22, 28, 34): 0-12.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=16 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=26 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Quality of Life Caregiver: The Caregiver Quality of Life Index-C
35.12 Quality of Life Score
Standard Deviation 8.52
36.88 Quality of Life Score
Standard Deviation 9.95

SECONDARY outcome

Timeframe: 1 month

Infection rate was assessed through self-report and verified through electronic medical chart review for each patient. Only patients with complete data on infection status (i.e., noted as having an "infection present" or "no infection present") were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=48 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Infection Rate (Biological Factor)
Infection Present · No Infection Present
3 Participants
5 Participants
Infection Rate (Biological Factor)
No Infection Present · No Infection Present
33 Participants
43 Participants

SECONDARY outcome

Timeframe: 3 months

Infection rate was assessed through self-report and verified through electronic medical chart review for each patient. Only patients with complete data on infection status (i.e., noted as having an "infection present" or "no infection present") were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=48 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Infection Rate (Biological Factor)
No Infection Present
32 Participants
39 Participants
Infection Rate (Biological Factor)
Infection Present
4 Participants
9 Participants

SECONDARY outcome

Timeframe: 6 months

Infection rate was assessed through self-report and verified through electronic medical chart review for each patient. Only patients with complete data on infection status (i.e., noted as having an "infection present" or "no infection present") were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=48 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Infection Rate (Biological Factor)
Infection Present
6 Participants
10 Participants
Infection Rate (Biological Factor)
No Infection Present
30 Participants
38 Participants

SECONDARY outcome

Timeframe: 12 months

Infection rate was assessed through self-report and verified through electronic medical chart review for each patient. Only patients with complete data on infection status (i.e., noted as having an "infection present" or "no infection present") were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=48 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Infection Rate (Biological Factor)
No Infection Present
30 Participants
37 Participants
Infection Rate (Biological Factor)
Infection Present
6 Participants
11 Participants

SECONDARY outcome

Timeframe: 1 month

Nurse or ER visits were assessed through self-report and verified through electronic medical record chart review for each patient. Only patients with complete data on ER/nurse visits (i.e., noted as having "ER or nurse visit" or "No ER or nurse visit" were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=49 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Visiting Nurse/ER Visits
No ER or Nurse Visit
29 Participants
41 Participants
Visiting Nurse/ER Visits
ER or Nurse Visit
7 Participants
8 Participants

SECONDARY outcome

Timeframe: 3 months

Nurse or ER visits were assessed through self-report and verified through electronic medical record chart review for each patient. Only patients with complete data on ER/nurse visits (i.e., noted as having "ER or nurse visit" or "No ER or nurse visit" were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=49 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Visiting Nurse/ER Visits
No ER or Nurse Visit
25 Participants
32 Participants
Visiting Nurse/ER Visits
ER or Nurse Visit
11 Participants
17 Participants

SECONDARY outcome

Timeframe: 6 months

Nurse or ER visits were assessed through self-report and verified through electronic medical record chart review for each patient. Only patients with complete data on ER/nurse visits (i.e., noted as having "ER or nurse visit" or "No ER or nurse visit" were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=49 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Visiting Nurse/ER Visits
No ER or Nurse Visit
21 Participants
29 Participants
Visiting Nurse/ER Visits
ER or Nurse Visit
15 Participants
20 Participants

SECONDARY outcome

Timeframe: 12 months

Nurse or ER visits were assessed through self-report and verified through electronic medical record chart review for each patient. Only patients with complete data on ER/nurse visits (i.e., noted as having "ER or nurse visit" or "No ER or nurse visit" were included in our analysis.

Outcome measures

Outcome measures
Measure
Intervention (Survivors)
n=36 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus access to Internet based software program, specifically designed for this research study. Software program contains relevant bladder cancer care instructions through videos, text, and graphics.
Usual Care Enhanced (Survivors)
n=49 Participants
Bladder cancer survivors receive standard instructions about post-op care from nursing staff plus the NCI published Facing forward cancer survivorship manual.
Visiting Nurse/ER Visits
No ER or Nurse Visit
21 Participants
24 Participants
Visiting Nurse/ER Visits
ER or Nurse Visit
15 Participants
25 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months

Population: We are unable to explore costs and potential savings associated with developing and implementing the RSBC intervention due to unscheduled nurse, ER visits or infection findings.

Costs relative to the development, implementation \& maintenance of the intervention and cost of post-treatment care from the medical and billing records.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 12 months

Population: We are unable to explore costs and potential savings associated with developing and implementing the RSBC intervention due to unscheduled nurse, ER visits or infection findings.

Costs relative to the development, implementation \& maintenance of the intervention and cost of post-treatment care from the medical and billing records.

Outcome measures

Outcome data not reported

Adverse Events

Intervention (Survivors)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 4 deaths

Intervention (Caregivers)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care Enhanced (Survivors)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 6 deaths

Usual Care Enhanced (Caregivers)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Michael Diefenbach

Northwell Health

Phone: 516-600-1400

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place